PAVmed Appoints Shaun O'Neil as Chief Operating Officer | Business Wire
PAVmed licenses cell-sampling device, test to diagnose Barrett's esophagus | Fierce Biotech
Micro-cap Pavmed takes on Medtronic, Exact with first DNA-based Barrett's esophagus test | 2019-12-27 | BioWorld
Medical Advisory Board – PAVmed Inc.
PAVmed Stock: Start Accumulating (NASDAQ:PAVM) | Seeking Alpha
PAVmed Selects Colombia for a First-in-Human Study on its PortIO™ Medical Device — bioaccess.™: CRO. REGULATORY. COMMERCIALIZATION
Is it Time to Dump PAVmed Inc (PAVM) Stock After it Is Higher By 2.53% in a Week?
Episode 19: Dr. Lishan Aklog, Chairman and CEO at PAVmed Inc. — bioaccess.™: CRO. REGULATORY. COMMERCIALIZATION
PAVmed: A True Game-Changer For Medical Devices (NASDAQ:PAVM) | Seeking Alpha
PAVmed Inc. | LinkedIn
PAVmed Inc. | LinkedIn
PAVmed | The Org
PAVmed partners to develop revolutionary ear device - Today's Medical Developments
PAVmed Primed To Deliver Significant Value For Shareholders (PAVM) | Seeking Alpha
PAVMed Is About To Enter The Commercialization Phase (NASDAQ:PAVM) | Seeking Alpha
PAVmed Inc. – Innovating at the speed of life.
PAVmed Inc. – Innovating at the speed of life.
PAVmed Inc. | LinkedIn
PavMed to spin off subsidiary Lucid Diagnostics - MassDevice
Investor Relations :: PAVmed Inc. (PAVM)
PAVmed files 510(k) FDA for PortIO Intraosseous Infusion System - Today's Medical Developments
PAVmed Inc. – Innovating at the speed of life.
PAVMed Is About To Enter The Commercialization Phase (NASDAQ:PAVM) | Seeking Alpha
PAVM Stock Price and Chart — NASDAQ:PAVM — TradingView
